Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Itron (ITRI) Research & Development (2016 - 2025)

Itron (ITRI) has disclosed Research & Development for 17 consecutive years, with $53.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 8.97% year-over-year to $53.1 million, compared with a TTM value of $117.7 million through Dec 2025, down 38.5%, and an annual FY2025 reading of $207.0 million, down 3.72% over the prior year.
  • Research & Development was $53.1 million for Q4 2025 at Itron, up from $26.2 million in the prior quarter.
  • Across five years, Research & Development topped out at $58.3 million in Q4 2024 and bottomed at $12.5 million in Q2 2025.
  • Average Research & Development over 5 years is $45.0 million, with a median of $49.6 million recorded in 2022.
  • The sharpest move saw Research & Development increased 18.88% in 2023, then crashed 76.51% in 2025.
  • Year by year, Research & Development stood at $49.9 million in 2021, then dropped by 6.48% to $46.6 million in 2022, then grew by 15.64% to $53.9 million in 2023, then grew by 8.2% to $58.3 million in 2024, then fell by 8.97% to $53.1 million in 2025.
  • Business Quant data shows Research & Development for ITRI at $53.1 million in Q4 2025, $26.2 million in Q3 2025, and $12.5 million in Q2 2025.